Induction of vascular smooth muscle cell growth by selective activation of the thrombin receptor Effect of heparin

FEBS Letters

Lamarche, I.¹  Dol, F.¹  Herbert, J.M.¹ 

[1] Sanofi Recherche, Haemobiology Research Department, 195 Route d'Espagne, 31036 Toulouse, France

关键词: Thrombin;    Vascular smooth muscle cell;    Mitogen;   

DOI  :  10.1016/0014-5793(92)81237-G

学科分类：生物化学/生物物理

来源: John Wiley & Sons Ltd.

【 摘 要 】

The synthetic peptide, SFLLRNPNDKYEPF, has been recently described as a peptide mimicking the new amino-terminus created by cleavage of the thrombin receptor, therefore acting as an agonist of the thrombin receptor. This peptide was a potent mitogen for rabbit arterial smooth muscle cells (SMC) and exhibited the same activity as that of native α-thrombin. Both compounds stimulated the proliferation of growth-arrested SMCs with half-maximum mitogenic responses at 1 nM. NAPAP, a synthetic inhibitor of the enzymatic activity of thrombin, specifically inhibited thrombin-induced SMC growth (IC₅₀ = 0.35 ± 0.04 μM) but was without effect on the mitogenic effect of the agonist peptide. These results therefore demonstrate that the mitogenic effect of α-thrombin for SMCs is intimately linked to its esterolytic activity. Heparin, which inhibited fetal calf serum-induced SMC growth, was without effect on thrombin-induced SMC growth but strongly reduced the mitogenic effect of the agonist peptide (IC₅₀ = 32 ± 5μ/ml). This effect was not related to the anti-coagulant activity of heparin but was highly dependent on molecular mass and on the global charge of the molecule and was also observed for other sulphated polysaccharides such as pentosan polysulphate.

【 授权许可】

Unknown